Screener
Axogen AXGN R&D
R&D at other companies
Other financials
Where this comes from
Reported directly by Axogen in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Axogen’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000805928-26-000094
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Gross profit | 50,674 | 42,018 | 96,863 | 76,951 |
| Costs and expenses | ||||
| Sales and marketing | 30,827 | 23,804 | 59,460 | 44,849 |
| Research and development | 8,589 | 6,853 | 16,106 | 12,944 |
| General and administrative | 13,414 | 9,689 | 26,285 | 19,147 |
| Total costs and expenses | 52,830 | 40,346 | 101,851 | 76,940 |
| (Loss) income from operations | (2,156) | 1,672 | (4,988) | 11 |
| Other income (expense) |
ITEM 1 — FINANCIAL STATEMENTS
FAQ
- What is Axogen's R&D?
- Axogen (AXGN) reported R&D of $8.59M in Q2 2026.
- How has Axogen's R&D changed year-over-year?
- Axogen's R&D increased by 25.3% year-over-year, from $6.85M to $8.59M.
- What is the long-term trend for Axogen's R&D?
- Over 4 years (2021 to 2025), Axogen's R&D has grown at a 8.0% compound annual growth rate (CAGR), from $24.18M to $32.89M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about Axogen's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude